ArticleFrontiers in oncology2025
Urinary bladder paraganglioma presenting with abdominal pain and elevated cardiac enzymes: a case report of atypical manifestations and diagnostic challenges.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Urinary bladder paraganglioma (UBPGL) is a very rare neuroendocrine tumor, accounting for 0.05% of all bladder neoplasms. Classic symptoms include paroxysmal hypertension, palpitations, and sweating triggered by micturition. However, atypical presentations may complicate the diagnosis. This report describes the case of a 35-year-old woman who presented with persistent lower abdominal pain and isolated elevation of cardiac enzymes. Imaging revealed a pelvic mass initially suspected to be adnexal pathology. Emergency laparoscopy identified a retroperitoneal mass adjacent to the bladder and an endometriotic ovarian cyst. Postoperative pathology confirmed UBPGL, with immunohistochemistry positive for neuroendocrine markers (CD56, chromogranin-A, synaptophysin). Elevated cardiac enzymes and a prolonged QTc interval were observed preoperatively, likely secondary to catecholamine-induced myocardial injury, although biochemical confirmation was not available. The patient recovered uneventfully after resection of the tumor. This case highlights the potential for UBPGL to have atypical cardiovascular manifestations, including isolated elevation of cardiac enzymes without classic hypertensive crises. Such findings may reflect catecholamine-driven cardiomyocyte stress, emphasizing the need for heightened suspicion in cases that present with unexplained abdominal pain and cardiac abnormalities. Diagnostic challenges arise from overlapping symptoms with gynecologic emergencies and the rarity of preoperative biochemical testing in acute settings. UBPGL should be considered in patients with a pelvic mass accompanied by unexplained cardiac abnormalities. Early resection remains curative, but multidisciplinary evaluation, including biochemical screening for catecholamine excess, is critical to mitigate the cardiovascular risk. Long-term surveillance is warranted in view of the potential for metastasis. This case underscores the importance of including rare neuroendocrine tumors in the differential diagnoses for atypical abdominal presentations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.